<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01072110</url>
  </required_header>
  <id_info>
    <org_study_id>HN-0001</org_study_id>
    <nct_id>NCT01072110</nct_id>
  </id_info>
  <brief_title>Confocal Laser Endomicroscopy (CLE) in Patients With Diarrhea</brief_title>
  <official_title>Confocal Laser Endomicroscopy in Patients With Diarrhea</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Erlangen-Nürnberg Medical School</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Erlangen-Nürnberg Medical School</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of this study is to determine the frequency of different gastrointestinal&#xD;
      disorders as the cause of diarrhea in patients at a tertiary referral center using confocal&#xD;
      laser endomicroscopy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background:&#xD;
&#xD;
      Diarrhea is characterized by frequent, loose, and watery bowel movements. Common causes&#xD;
      include various gastrointestinal infections (e.g. clostridium difficile, salmonella),&#xD;
      inflammatory bowel disease (ulcerative colitis, Crohn´s disease), drugs (e.g. antibiotics)&#xD;
      and malabsorption syndromes (e.g. celiac and Whipple's disease). Confocal laser&#xD;
      endomicroscopy (CLE) is rapidly emerging as a valuable tool for gastrointestinal endoscopic&#xD;
      imaging, enabling the endoscopist to obtain an &quot;optical biopsy&quot; of the gastrointestinal&#xD;
      mucosa during the endoscopic procedure.&#xD;
&#xD;
      Scope:&#xD;
&#xD;
      In patients with diarrhea.&#xD;
&#xD;
      Methods:&#xD;
&#xD;
      Patients were randomized in two groups. Group 1: Patients underwent standard video&#xD;
      colonoscopy for the evaluation of their symptoms. Group 2: During the endoscopic procedure&#xD;
      CLE will be performed additionally.&#xD;
&#xD;
      Procedure:&#xD;
&#xD;
      The patient underwent colonoscopy. In Group 2 patients´ will receive intravenous fluorescein&#xD;
      or topical mucosal staining with acriflavin or cresyl violet during the procedure, followed&#xD;
      by in-vivo CLE of the tissue. Confocal images are digitally saved and analyzed afterwards.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 2010</start_date>
  <completion_date type="Actual">February 2014</completion_date>
  <primary_completion_date type="Actual">January 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To determine the frequency of different gastrointestinal disorders as the cause of diarrhea in patients at a tertiary referral center using confocal laser endomicroscopy.</measure>
    <time_frame>February 2012</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To investigate whether CLE has a higher sensitivity and specificity than standard colonoscopy in the diagnosis of the cause of diarrhea.</measure>
    <time_frame>February 2012</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">200</enrollment>
  <condition>Diarrhea</condition>
  <arm_group>
    <arm_group_label>Group 1: Patients with diarrhea undergoing endoscopy</arm_group_label>
    <description>Standard video colonoscope.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2: Patients with diarrhea undergoing endoscopy.</arm_group_label>
    <description>Confocal laser endomicroscopy (CLE).</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Colonoscopy</intervention_name>
    <description>Patients will undergo colonoscopy for evaluation of their symptoms.</description>
    <arm_group_label>Group 1: Patients with diarrhea undergoing endoscopy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Confocal Laser Endomicroscopy</intervention_name>
    <description>Patients will undergo CLE during their endoscopy. Findings will be compared to group 1.</description>
    <arm_group_label>Group 2: Patients with diarrhea undergoing endoscopy.</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients of a tertiary referral hospital.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Written informed consent&#xD;
&#xD;
          -  Age 18-85 years&#xD;
&#xD;
          -  Ability of subjects to understand character and individual consequences of clinical&#xD;
             trial&#xD;
&#xD;
          -  Subjects undergoing colonoscopy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inability to provide written informed consent&#xD;
&#xD;
          -  Severe Coagulopathy (Prothrombin time &lt; 50% of control, Partial thromboplastin time &gt;&#xD;
             50 s)&#xD;
&#xD;
          -  Impaired renal function (Creatinine &gt; 1.2 mg/dl)&#xD;
&#xD;
          -  Pregnancy or breast feeding&#xD;
&#xD;
          -  Active gastrointestinal bleeding&#xD;
&#xD;
          -  Known allergy to fluorescein, acriflavin or cresyl violet&#xD;
&#xD;
          -  Residing in institutions (e.g. prison)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Markus F. Neurath, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Medicine I, University of Erlangen-Nuremberg</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Erlangen</city>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>February 17, 2010</study_first_submitted>
  <study_first_submitted_qc>February 18, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 19, 2010</study_first_posted>
  <last_update_submitted>December 10, 2020</last_update_submitted>
  <last_update_submitted_qc>December 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Patients with diarrhea</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diarrhea</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

